Abstract
Oral and intrathecal baclofen (ITB) have been associated with epileptic seizures. The authors observed a higher incidence of epileptic seizures in 99 patients with multiple sclerosis (MS) treated with ITB vs a matched control group (7% vs 1%, p < 0.05). Three patients with MS on ITB developed status epilepticus. Seizures were often associated with additional triggering factors.
Original language | English (US) |
---|---|
Pages (from-to) | 1086-1087 |
Number of pages | 2 |
Journal | Neurology |
Volume | 64 |
Issue number | 6 |
DOIs | |
State | Published - Mar 22 2005 |
ASJC Scopus subject areas
- Clinical Neurology